Clinical Trial Update: A Phase 3 Study of TS-172 in Hyperphosphatemia Patients on Hemodialysis [Phase 3]

View source ↗

Summary

This update reports the completion of a Phase 3 study evaluating TS-172 for treating hyperphosphatemia in patients on hemodialysis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperphosphatemia

Drugs mentioned

• TS-172

Snippet

Sponsor: Taisho Pharmaceutical Co., Ltd. | Conditions: Hyperphosphatemia Patients on Hemodialysis | Phase 3 | Status: COMPLETED